LINDA JOHNSON: Open Payments
NPI 1902193741 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 9 payments from 7 companies in 2025. Trend: 2023 $165 · 2024 $192 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Dilon Technologies, Inc. | 1 | $178 |
| AstraZeneca Pharmaceuticals LP | 1 | $104 |
| Merck Sharp & Dohme LLC | 3 | $94 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
Products named: HEMOBLAST BELLOWS, ENHERTU, KEYTRUDA, MYRISK, RYBREVANT, Magtrace, QINLOCK.
Industry payments across LA — which companies pay providers there.
